Clinical Trials in Phoenix

Showing 161-180 of 12,606 trials

Growth Hormone for the Treatment of Gastroparesis

NCT06803589

The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

Gastroparesis

Mayo Clinic10 participantsStarted Oct 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States

RECRUITINGNA< 1 mile

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

NCT05866419

The primary objective of the clinical investigation is to demonstrate successful clinical use of the ThecaFlex DRx™ System in delivering nusinersen in subjects with spinal muscular atrophy (SMA). All enrolled subjects will undergo implantation of the investigational device (ThecaFlex DRx™ System) and will be followed for 12 months after receiving the implant. The 12-month data will be used to assess the primary endpoint support a Pre-Market Approval (PMA) application.

Spinal Muscular AtrophySpine DeformityScoliosis

Alcyone Therapeutics, Inc90 participantsStarted Nov 2023

Phoenix, Arizona, United States • Orange, California, United States • Palo Alto, California, United States +18 more locations

Growth Hormone for the Treatment of Gastroparesis

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

Find Trials by Condition in Phoenix

Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial